InvestorsHub Logo

Chabojilo

10/19/13 10:25 AM

#18148 RE: HDGabor #18145

The label must be Vascepa added to statin to reduce trigs in order to treat at risk patients with no conclusive evidence that shows treatment will prevent outcomes, that it is only based on strong circumstantial evidence (PERIOD)

LET THE DOCTORS DECIDE BASED ON THEIR KNOWLEDGE LEVEL!!!